$4.24
-0.08 (-1.85%)
Sangamo Biosciences, Inc. (NASDAQ:SGMO)
CAPS Rating:
The Company deals in the research, development and commercialization of DNA-binding proteins for the therapeutic regulation and modification of disease-related genes.
RSS Headlines
Fool UK